If you follow vaccine policy closely, you’ve probably learned to brace yourself on Friday afternoons. Just as the weekend rolls in, my team has a standing bet on the night’s bombshell: guessing what gets pulled, which committee gets gutted, and which stack of evidence gets quietly waved away while the reporters log off. It started as a dark joke but stopped being funny a while ago.
The pediatric childhood schedule fight has largely gone quiet since March, when a court froze the administration’s Advisory Committee on Immunization Practices (ACIP) overhaul, even as the Friday personnel churn rolled on. Now all the chips seem to be back on the table.
That habit of bracing—of trying to guess what’s coming next—is one my father would have understood. He was a gambler who also taught me chess, and two of his lessons have stuck with me. From the card table: Play the player, not the cards. What someone is holding matters less than who they are and what they want you to believe. From the chessboard: Think a few moves ahead, because the move that decides a game is rarely the one that looks like it’s doing something.
Lipstick on a weak argument
Both have been on my mind since the White House publishedan executive order on Friday, May 29, titled “Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries.”
“Executive order” has come to signal something swift and unilateral, already in force before you can respond. This one plays on fear without earning it. Read only the cards, and there’s not much here. The order tells the Centers for Disease Control and Prevention (CDC) and its ACIP to review a federal “scientific assessment” (a December-ordered report comparing the US childhood schedule with those of peer nations) and consider updates to the childhood schedule.
On its own, the order does not change any recommendations, not to mention there’s no functioning ACIP to act on it right now. It also makes a point of stating that vaccines across all categories should remain covered without cost-sharing by private insurance, Medicaid, the Children’s Health Insurance Program (CHIP), and the Vaccines for Children Program. For now, the schedule recommended by the CDC and American Academy of Pediatrics as of 2025 remains in effect.
This order is easy to mistake for a reinstatement of the January schedule cut it refers back to, so a quick refresher: The CDC pared the routine childhood schedulefrom coverage of 17 diseases to 11, shifting shots for flu, COVID-19, rotavirus, and others into “high-risk” or “shared decision-making” tiers. In March, a federal court struck down the schedule cut in a ruling that also froze the administration’s effort to reconstitute ACIP. The court found that officials had pushed the schedule changes through without a formal ACIP vote, public comment, or other processes required by law.
Friday’s executive order doesn’t restore any of the administration’s proposed schedule changes. It simply points back to theDecember memorandum that started the effort and treats its findings as settled.
Ultimately, the substance of the pediatric vaccine schedule hasn’t actually changed; only the packaging has.
The phrase “best practices from peer, developed countries” is the same argument from December, and theproblems with it haven’t changed. Denmark, the model the administration keeps reaching for, is the lowest outlier on the list, not a representative peer. It’s a country of about 6million people, roughly the size of Maryland, with universal healthcare, medical records that follow a person from birth to death, and 46 weeks of paid parental leave. We have none of that.
AStatNews analysis counting the diseases each country vaccinates against found that most peer nations land around 14, and the old US schedule sat only modestly above that, and was not the wild high outlier the “more than any peer nation” line implies. The January cut didn’t bring us in line with those peers; it dropped us well below them, to 11, into the same low-outlier company as Denmark. AVaxopedia rundown went country by country and reached the same conclusion: most peer nations’ schedules track closely with the United States, and a few recommend even more vaccines.
Ultimately, the substance of the pediatric vaccine schedule hasn’t actually changed; only the packaging has. The same cherry-picked comparison now arrives as a formal “scientific assessment,” acknowledged in the order as a “guiding resource for the Federal Government.” This assessment was written bytwo allies of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. allies—Tracy Beth Høeg, a sports medicine physician, and Martin Kulldorff, a biostatistician—neither of whom works in vaccine policy. Dressing up a weak argument to look authoritative takes deliberate work, and people don’t do that work for no reason.
2 plausible next moves
So, thinking a few moves ahead: What is this setting up?
Two plausible answers keep surfacing, and law professor Dorit Reiss, an expert on vaccine law specifically, haslanded on the same two.
The first is that it’s a bluff.Reuters reported, citing administration officials, that the White House told Kennedy to ease off vaccines before November, because its own polling shows that even Make America Healthy Again voters back routine childhood immunization and that vaccine skepticism is, in one Republican pollster’s words, “political poison.”
Kennedydenied, under oath, that anyone gave him that instruction, but the pattern is hard to miss. An order that changes nothing and protects insurance coverage gives the base a symbolic win, while the real schedule and everyone’s access to recommended vaccines stay put through midterms.
The trouble with reading it as pure theater is that the quiet on the surface doesn’t match the activity underneath. Even as he says little in public, Kennedy isdriving a sprawling research effort, reportedly costing tens of millions, to hunt for links between vaccines and autism or other chronic conditions, and he plainly said the point of building such evidence is to lay the groundwork for legal action.
That tips me toward the second reading—a strategic undermining. The January schedule changes were struck down on process, so the pieces now falling into place look like a rebuild on firmer footing: a formal assessment in the record, a directive aimed at a future ACIP, and language about sorting the schedule into “categories.”
The administration has evenquietly rewritten the ACIP charter to broaden who can serve, a change legal scholars read as an effort to seat a new panel that can survive the next court challenge. You don’t have to strip a vaccine from coverage to undermine it. Reclassify it from “routine” to “high risk only,” and the recommendation that schools, insurers, and pediatricians follow quietly erodes, while the coverage language lets the administration say nothing was taken away.
What complicates all of this is that, from where we sit, we can’t be sure which reading is right. We’ve lost enough of these fights that we’ve stopped reading any single move on its own terms. A quiet order looks like a trap, a pause looks like a setup, and the line between theater and threat is blurred. The confusion does its own work, keeping a whole field braced for the next hit instead of focused on the work in front of us, which suits the people making the moves just fine.
The confusion does its own work, keeping a whole field braced for the next hit instead of focused on the work in front of us.
I can’t see the whole board, so I’ll name the squares I’m watching:
- Whether a reconstituted ACIP convenes this summer (which reporting suggests is coming within weeks) and whether its new charter holds up.
- How the “categories” in the scientific assessment get defined, because that’s where vaccines will actually come off the routine schedule.
- Whether the research effort already under way gets used to manufacture a rationale that the January schedule change never had.
My father used to say the costliest mistake at the table is walking away from a game that isn’t over because you’re tired of losing. So, we keep watching the board, we keep following the schedule we have, the one that hasprevented more than a million deaths since 1994, and we wait to see what this move sets up. The next one is theirs.
Dr. Steier is a public health scientist and scientific communicator. She is the founder of Unbiased Science, an organization that uses data visualizations, real-world analogies, and human voice to communicate complex scientific concepts for public understanding via multiple media modalities.
The opinions voiced in CIDRAP Op-Ed pieces are the authors’ own and do not necessarily represent the official position of CIDRAP.